Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Feb;89(2):602-616.
doi: 10.1111/bcp.15583. Epub 2022 Nov 23.

Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis

Nayeon Ahn  1   2 , Michael Nolde  1   2 , Evamaria Krause  3 , Florian Güntner  4 , Alexander Günter  4 , Martin Tauscher  5 , Roman Gerlach  5 , Christa Meisinger  2 , Jakob Linseisen  1   2 , Sebastian-Edgar Baumeister  6 , Ina-Maria Rückert-Eheberg  1   2
Affiliations
Free article
Meta-Analysis

Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis

Nayeon Ahn et al. Br J Clin Pharmacol. 2023 Feb.
Free article

Abstract

Aim: Previous studies on the association between proton pump inhibitor (PPI) intake and the increased risk of dementia has shown discrepancies in their conclusions. We aimed to provide updated evidence based on extensive bias assessments and quantitative sensitivity analyses.

Methods: We searched the databases PubMed, EMBASE, SCOPUS, CENTRAL and clinicaltrials.gov for prospective studies that examined an association between PPI use and dementia, up to February 2022. Each study was assessed using the Cochrane risk of bias assessment tools for non-randomized studies of interventions (ROBINS-I) or randomized trials (RoB2). Pooled risk ratios (RRs) and 95% prediction intervals were computed using random-effects models. Sensitivity analyses were adjusted for small-study bias.

Results: We included nine observational studies with 204 108 dementia cases in the primary analysis on the association between PPI use vs. non-use and dementia, and the RR was 1.16 (95% CI = 1.00; 1.35). After adjusting for small-study bias by Copas selection model and Rücker's shrinkage procedure, the RR was 1.16 (1.02; 1.32) and 1.15 (1.13; 1.17), respectively. A subgroup analysis of PPI use vs. non-use regarding Alzheimer's disease risk yielded an RR of 1.15 (0.89; 1.50). The secondary analysis on the risk of dementia by use of PPI vs. histamine-2 receptor antagonist showed an RR of 1.03 (0.66; 1.62).

Conclusion: This meta-analysis provided no clear evidence for an association between PPI intake and the risk of dementia. Due to discrepancies in sensitivity analyses, however, some risk of dementia by PPI use cannot be ruled out. Since an unequivocal conclusion is still pending, further research is warranted.

Keywords: Alzheimer's disease; cognitive impairment; dementia; proton pump inhibitors.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88-106. doi:10.1016/S1474-4422(18)30403-4
    1. Luengo-Fernandez R, Leal J, Gray A. UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia. BMJ Open. 2015;5(4):e006648. doi:10.1136/bmjopen-2014-006648
    1. Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017;152(4):706-715. doi:10.1053/j.gastro.2017.01.031
    1. Rückert-Eheberg IM, Nolde M, Ahn N, et al. Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018. Eur J Clin Pharmacol. 2022;78(4):657-667. doi:10.1007/s00228-021-03257-z
    1. Ahrens D, Behrens G, Himmel W, Kochen MM, Chenot JF. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int J Clin Pract. 2012;66(8):767-773. doi:10.1111/j.1742-1241.2012.02973.x

Publication types

Substances

LinkOut - more resources